The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs

British Journal of Pharmacology

Volumn 172, Issue 11, 2015, Pages 2733-2747

  He, Y ^a   Chevillet, J R ^b   Liu, G ^c   Kim, T K ^b   Wang, K ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^c NORTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; MICRORNA; REGULATOR PROTEIN; TRANSCRIPTOME; TRANSPORTER PROTEIN; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; CARRIER PROTEIN; CELL RECEPTOR; CYTOCHROME P450; DRUG;

DNA METHYLATION; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG METABOLISM; EPIGENETICS; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENOME ANALYSIS; HISTONE METHYLATION; HUMAN; MICROBIOME; MOLECULAR DYNAMICS; NONHUMAN; PHASE TRANSITION; PREDICTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; REVIEW; TRANSCRIPTOMICS; ABSORPTION; BIOTRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

ABSORPTION, PHYSIOLOGICAL; BIOTRANSFORMATION; CYTOCHROME P-450 ENZYME SYSTEM; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICRORNAS; PHARMACEUTICAL PREPARATIONS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTOME;

EID: 84929148380     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12968     Document Type: Review

References (195)

1. Adams BD, Furneaux H, White BA, (2007). The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 21: 1132-1147.
2. Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, Busini V, Hossain N, et al. (2008). A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol 26: 561-569.
3. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al (2013a). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
4. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Nuclear Hormone Receptors. Br J Pharmacol 170, 1652-1675
5. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al (2013c). The Concise Guide to PHARMACOLOGY 2013/14: Transporters. Br J Pharmacol 170: 1706-1796.
6. Allen RM, Marquart TJ, Albert CJ, Suchy FJ, Wang DQ, Ananthanarayanan M, et al. (2012). miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity. EMBO Mol Med 4: 882-895.
7. Alomar MJ, (2014). Factors affecting the development of adverse drug reactions (Review article). Saudi Pharm J 22: 83-94.
8. Ambros V, (2001). microRNAs: tiny regulators with great potential. Cell 107: 823-826.
9. Azizi M, Teimoori-Toolabi L, Arzanani MK, Azadmanesh K, Fard-Esfahani P, Zeinali S, (2014). MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines. Cancer Biol Ther 15: 419-427.
10. el Azzouzi H, Leptidis S, Dirkx E, Hoeks J, van Bree B, Brand K, et al. (2013). The hypoxia-inducible microRNA cluster miR-199-214 targets myocardial PPARδ and impairs mitochondrial fatty acid oxidation. Cell Metab 18: 341-354.
11. Bao L, Haque A, Jackson K, Hazari S, Moroz K, Jetly R, et al. (2011). Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model. Am J Pathol 178: 838-852.
12. Bao L, Hazari S, Mehra S, Kaushal D, Moroz K, Dash S, (2012). Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. Am J Pathol 180: 2490-2503.
13. Bartel DP, (2009). MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
14. Baudry A, Mouillet-Richard S, Schneider B, Launay JM, Kellermann O, (2010). miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 329: 1537-1541.
15. Belanger A, Pelletier G, Labrie F, Barbier O, Chouinard S, (2003). Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 14: 473-479.
16. Bell LC, Wang J, (2012). Probe ADME and test hypotheses: a PATH beyond clearance in vitro-in vivo correlations in early drug discovery. Expert Opin Drug Metab Toxicol 8: 1131-1155.
17. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M, (2012). An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57-74.
18. Bitarte N, Bandres E, Boni V, Zarate R, Rodriguez J, Gonzalez-Huarriz M, et al. (2011). MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. Stem Cells 29: 1661-1671.
19. Borel F, Han R, Visser A, Petry H, van Deventer SJ, Jansen PL, et al. (2012). Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs. Hepatology 55: 821-832.
20. Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude Elferink RP, Chowdhury JR, et al. (1994). Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 269: 17960-17964.
21. Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, Meister M, et al. (2007). The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res 67: 1419-1423.
22. Caldwell GW, Yan Z, Tang W, Dasgupta M, Hasting B, (2009). ADME optimization and toxicity assessment in early- and late-phase drug discovery. Curr Top Med Chem 9: 965-980.
23. Candelaria M, de la Cruz-Hernandez E, Perez-Cardenas E, Trejo-Becerril C, Gutierrez-Hernandez O, Duenas-Gonzalez A, (2010). Pharmacogenetics and pharmacoepigenetics of gemcitabine. Med Oncol 27: 1133-1143.
24. Chen BF, Gu S, Suen YK, Li L, Chan WY, (2014). microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer. Epigenetics 9: 119-128.
25. Chen F, Chen C, Yang S, Gong W, Wang Y, Cianflone K, et al. (2012a). Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2. PLoS ONE 7: e39197.
26. Chen J, Tian W, Cai H, He H, Deng Y, (2012b). Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer. Med Oncol 29: 2527-2534.
27. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, et al. (2006). The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38: 228-233.
28. Chuturgoon AA, Phulukdaree A, Moodley D, (2014). Fumonisin B(1) modulates expression of human cytochrome P450 1b1 in human hepatoma (Hepg2) cells by repressing Mir-27b. Toxicol Lett 227: 50-55.
29. Conaco C, Otto S, Han JJ, Mandel G, (2006). Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci U S A 103: 2422-2427.
30. Dalmasso G, Nguyen HT, Yan Y, Laroui H, Charania MA, Ayyadurai S, et al. (2011a). Microbiota modulate host gene expression via microRNAs. PLoS ONE 6: e19293.
31. Dalmasso G, Nguyen HT, Yan Y, Laroui H, Charania MA, Obertone TS, et al. (2011b). MicroRNA-92b regulates expression of the oligopeptide transporter PepT1 in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 300: G52-G59.
32. Dannenberg LO, Edenberg HJ, (2006). Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation. BMC Genomics 7: 181.
33. Dluzen DF, Sun D, Salzberg AC, Jones N, Bushey RT, Robertson GP, et al. (2014). Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3p. J Pharmacol Exp Ther 348: 465-477.
34. Drayton RM, Peter S, Myers K, Miah S, Dudziec E, Bryant HE, et al. (2014). MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer. Oncotarget 5: 6375-6386.
35. Duursma AM, Kedde M, Schrier M, le Sage C, Agami R, (2008). miR-148 targets human DNMT3b protein coding region. RNA 14: 872-877.
36. Emoto C, Murayama N, Rostami-Hodjegan A, Yamazaki H, (2010). Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution. Curr Drug Metab 11: 678-685.
37. Enright AJ, John B, Gaul U, Tuschl T, Sander C, Marks DS, (2003). MicroRNA targets in Drosophila. Genome Biol 5: R1.
38. Esteller M, (2011). Non-coding RNAs in human disease. Nat Rev Genet 12: 861-874.
39. Evrard A, Mbatchi L, (2012). Genetic polymorphisms of drug metabolizing enzymes and transporters: the long way from bench to bedside. Curr Top Med Chem 12: 1720-1729.
40. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, et al. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 104: 15805-15810.
41. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009). Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
42. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J, (2010). miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31: 766-776.
43. Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, et al. (2009). MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113: 6411-6418.
44. Gillen AE, Gosalia N, Leir SH, Harris A, (2011). MicroRNA regulation of expression of the cystic fibrosis transmembrane conductance regulator gene. Biochem J 438: 25-32.
45. Glubb DM, Innocenti F, (2011). Mechanisms of genetic regulation in gene expression: examples from drug metabolizing enzymes and transporters. Wiley Interdiscip Rev Syst Biol Med 3: 299-313.
46. Godlewski J, Nowicki MO, Bronisz A, Williams S, Otsuki A, Nuovo G, et al. (2008). Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res 68: 9125-9130.
47. Goedeke L, Vales-Lara FM, Fenstermaker M, Cirera-Salinas D, Chamorro-Jorganes A, Ramirez CM, et al. (2013). A regulatory role for microRNA 33∗ in controlling lipid metabolism gene expression. Mol Cell Biol 33: 2339-2352.
48. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008). miRBase: tools for microRNA genomics. Nucleic Acids Res 36 (Database issue): D154-D158.
49. Guan YJ, Yang X, Wei L, Chen Q, (2011). MiR-365: a mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4. FASEB J 25: 4457-4466.
50. Guo L, Liu Y, Bai Y, Sun Y, Xiao F, Guo Y, (2010). Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Eur J Cancer 46: 1692-1702.
51. Haenisch S, Laechelt S, Bruckmueller H, Werk A, Noack A, Bruhn O, et al. (2011). Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379. Mol Pharmacol 80: 314-320.
52. Haiser HJ, Turnbaugh PJ, (2013). Developing a metagenomic view of xenobiotic metabolism. Pharmacol Res 69: 21-31.
53. Han X, Liehr JG, (1994). DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. Carcinogenesis 15: 997-1000.
54. Harmsen S, Meijerman I, Febus CL, Maas-Bakker RF, Beijnen JH, Schellens JH, (2010). PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line. Cancer Chemother Pharmacol 66: 765-771.
55. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
56. Ivanov M, Kacevska M, Ingelman-Sundberg M, (2012). Epigenomics and interindividual differences in drug response. Clin Pharmacol Ther 92: 727-736.
57. Jennewein C, von Knethen A, Schmid T, Brune B, (2010). MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA destabilization. J Biol Chem 285: 11846-11853.
58. Jeon HM, Sohn YW, Oh SY, Kim SH, Beck S, Kim S, et al. (2011). ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9∗-mediated suppression of SOX2. Cancer Res 71: 3410-3421.
59. Ji J, Zhang J, Huang G, Qian J, Wang X, Mei S, (2009). Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 583: 759-766.
60. Jiao X, Zhao L, Ma M, Bai X, He M, Yan Y, et al. (2013). MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2). Breast Cancer Res Treat 139: 717-730.
61. Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V, (2009). Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 36: 61-74.
62. Kacevska M, Ivanov M, Wyss A, Kasela S, Milani L, Rane A, et al. (2012). DNA methylation dynamics in the hepatic CYP3A4 gene promoter. Biochimie 94: 2338-2344.
63. Kalscheuer S, Zhang X, Zeng Y, Upadhyaya P, (2008). Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 29: 2394-2399.
64. Kang MH, Zhang LH, Wijesekara N, de Haan W, Butland S, Bhattacharjee A, et al. (2013). Regulation of ABCA1 protein expression and function in hepatic and pancreatic islet cells by miR-145. Arterioscler Thromb Vasc Biol 33: 2724-2732.
65. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI, (2011). Human nutrition, the gut microbiome and the immune system. Nature 474: 327-336.
66. Kellis M, Wold B, Snyder MP, Bernstein BE, Kundaje A, Marinov GK, et al. (2014). Defining functional DNA elements in the human genome. Proc Natl Acad Sci U S A 111: 6131-6138.
67. Kida K, Nakajima M, Mohri T, Oda Y, Takagi S, Fukami T, et al. (2011). PPARα is regulated by miR-21 and miR-27b in human liver. Pharm Res 28: 2467-2476.
68. Kim J, Yoon H, Ramirez CM, Lee SM, Hoe HS, Fernandez-Hernando C, (2012). MiR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression. Exp Neurol 235: 476-483.
69. Kim SY, Kim AY, Lee HW, Son YH, Lee GY, Lee JW, et al. (2010). miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem Biophys Res Commun 392: 323-328.
70. Kim VN, Han J, Siomi MC, (2009). Biogenesis of small RNAs in animals. Nature reviews 10: 126-139.
71. Kloosterman WP, Plasterk RH, (2006). The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450.
72. Komagata S, Nakajima M, Takagi S, Mohri T, Taniya T, Yokoi T, (2009). Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b. Mol Pharmacol 76: 702-709.
73. Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, et al. (2008). Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 7: 2152-2159.
74. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. (2005). Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689.
75. Kumar P, Luo Y, Tudela C, Alexander JM, Mendelson CR, (2013). The c-Myc-regulated microRNA-17∼92 (miR-17∼92) and miR-106ã363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation. Mol Cell Biol 33: 1782-1796.
76. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T, (2001). Identification of novel genes coding for small expressed RNAs. Science 294: 853-858.
77. Lee JJ, Drakaki A, Iliopoulos D, Struhl K, (2012). MiR-27b targets PPARγ to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells. Oncogene 31: 3818-3825.
78. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, et al. (2004). MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23: 4051-4060.
79. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA, (1998). The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102: 1016-1023.
80. Lewis BP, Burge CB, Bartel DP, (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
81. Lewis DF, (2004). 57 varieties: the human cytochromes P450. Pharmacogenomics 5: 305-318.
82. Li H, Xie H, Liu W, Hu R, Huang B, Tan YF, et al. (2009a). A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Invest 119: 3666-3677.
83. Li KK, Pang JC, Ching AK, Wong CK, Kong X, Wang Y, et al. (2009b). miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum Pathol 40: 1234-1243.
84. Li X, Pan YZ, Seigel GM, Hu ZH, Huang M, Yu AM, (2011). Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells. Biochem Pharmacol 81: 783-792.
85. Liang Z, Wu H, Xia J, Li Y, Zhang Y, Huang K, et al. (2010). Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 79: 817-824.
86. Liao R, Sun J, Zhang L, Lou G, Chen M, Zhou D, et al. (2008). MicroRNAs play a role in the development of human hematopoietic stem cells. J Cell Biochem 104: 805-817.
87. Liu N, Pan T, (2014). RNA epigenetics. Transl Res doi: 10.1016/j.trsl.2014.04.003; [Epub ahead of print].
88. Ma MT, He M, Wang Y, Jiao XY, Zhao L, Bai XF, et al. (2013). MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2). Cancer Lett 339: 107-115.
89. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, et al. (2005). Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15: 677-685.
90. Maisel M, Habisch HJ, Royer L, Herr A, Milosevic J, Hermann A, et al. (2010). Genome-wide expression profiling and functional network analysis upon neuroectodermal conversion of human mesenchymal stem cells suggest HIF-1 and miR-124a as important regulators. Exp Cell Res 316: 2760-2778.
91. Markova SM, Kroetz DL, (2014). ABCC4 is regulated by microRNA-124a and microRNA-506. Biochem Pharmacol 87: 515-522.
92. Marquart TJ, Allen RM, Ory DS, Baldan A, (2010). miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci U S A 107: 12228-12232.
93. Melo S, Villanueva A, Moutinho C, Davalos V, Spizzo R, Ivan C, et al. (2011). Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A 108: 4394-4399.
94. Miko E, Margitai Z, Czimmerer Z, Varkonyi I, Dezso B, Lanyi A, et al. (2011). miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5. FEBS Lett 585: 1191-1196.
95. Mohri T, Nakajima M, Takagi S, Komagata S, Yokoi T, (2009). MicroRNA regulates human vitamin D receptor. Int J Cancer 125: 1328-1333.
96. Mohri T, Nakajima M, Fukami T, Takamiya M, Aoki Y, Yokoi T, (2010). Human CYP2E1 is regulated by miR-378. Biochem Pharmacol 79: 1045-1052.
97. Moya PR, Wendland JR, Salemme J, Fried RL, Murphy DL, (2013). miR-15a and miR-16 regulate serotonin transporter expression in human placental and rat brain raphe cells. Int J Neuropsychopharmacol 16: 621-629.
98. Murray GI, Taylor MC, McFadyen MC, McKay JA, Greenlee WF, Burke MD, et al. (1997). Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57: 3026-3031.
99. Nagar S, Remmel RP, (2006). Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer. Oncogene 25: 1659-1672.
100. Nakajima T, Aoyama T, (2000). Polymorphism of drug-metabolizing enzymes in relation to individual susceptibility to industrial chemicals. Ind Health 38: 143-152.
101. Newbold RR, Liehr JG, (2000). Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 60: 235-237.
102. Ng EK, Tsang WP, Ng SS, Jin HC, Yu J, Li JJ, et al. (2009). MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer 101: 699-706.
103. Ng EK, Li R, Shin VY, Siu JM, Ma ES, Kwong A, (2014). MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells. Tumour Biol 35: 2591-2598.
104. Noh JH, Chang YG, Kim MG, Jung KH, Kim JK, Bae HJ, et al. (2013). MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. Cancer Lett 335: 455-462.
105. Noonan EJ, Place RF, Pookot D, Basak S, Whitson JM, Hirata H, et al. (2009). miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 28: 1714-1724.
106. Ou Z, Wada T, Gramignoli R, Li S, Strom SC, Huang M, et al. (2011). MicroRNA hsa-miR-613 targets the human LXRα gene and mediates a feedback loop of LXRα autoregulation. Mol Endocrinol 25: 584-596.
107. Overhoff MG, Garbe JC, Koh J, Stampfer MR, Beach DH, Bishop CL, (2014). Cellular senescence mediated by p16INK4A-coupled miRNA pathways. Nucleic Acids Res 42: 1606-1618.
108. Padmanabhan R, Chen KG, Gillet JP, Handley M, Mallon BS, Hamilton RS, et al. (2012). Regulation and expression of the ATP-binding cassette transporter ABCG2 in human embryonic stem cells. Stem Cells 30: 2175-2187.
109. Pan YZ, Gao W, Yu AM, (2009a). MicroRNAs regulate CYP3A4 expression via direct and indirect targeting. Drug Metab Dispos 37: 2112-2117.
110. Pan YZ, Morris ME, Yu AM, (2009b). MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol 75: 1374-1379.
111. Pan YZ, Zhou A, Hu Z, Yu AM, (2013). Small nucleolar RNA-derived microRNA hsa-miR-1291 modulates cellular drug disposition through direct targeting of ABC transporter ABCC1. Drug Metab Dispos 41: 1744-1751.
112. Pandey DP, Picard D, (2009). miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol Cell Biol 29: 3783-3790.
113. Pastore A, Federici G, Bertini E, Piemonte F, (2003). Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta 333: 19-39.
114. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucleic Acids Res 42 (Database Issue): D1098-1106.
115. Peng D, Belkhiri A, Hu T, Chaturvedi R, Asim M, Wilson KT, et al. (2012). Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells. Gut 61: 1250-1260.
116. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, et al. (2004). Identification of virus-encoded microRNAs. Science 304: 734-736.
117. Plant NJ, Gibson GG, (2003). Evaluation of the toxicological relevance of CYP3A4 induction. Curr Opin Drug Discov Devel 6: 50-56.
118. Png KJ, Yoshida M, Zhang XH, Shu W, Lee H, Rimner A, et al. (2011). MicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancer. Genes Dev 25: 226-231.
119. Pogribny IP, Filkowski JN, Tryndyak VP, Golubov A, Shpyleva SI, Kovalchuk O, (2010). Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin. Int J Cancer 127: 1785-1794.
120. Pullen TJ, da Silva Xavier G, Kelsey G, Rutter GA, (2011). miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol Cell Biol 31: 3182-3194.
121. Qi L, Hongjuan H, Ning G, Zhengbin H, Yanjiang X, Tiebo Z, et al. (2013). miR-370 is stage-specifically expressed during mouse embryonic development and regulates Dnmt3a. FEBS Lett 587: 775-781.
122. Ramachandran S, Karp PH, Osterhaus SR, Jiang P, Wohlford-Lenane C, Lennox KA, et al. (2013). Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs. Am J Respir Cell Mol Biol 49: 544-551.
123. Ramirez CM, Davalos A, Goedeke L, Salerno AG, Warrier N, Cirera-Salinas D, et al. (2011). MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arterioscler Thromb Vasc Biol 31: 2707-2714.
124. Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, et al. (2010). MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328: 1570-1573.
125. Rodrigues AC, Li X, Radecki L, Pan YZ, Winter JC, Huang M, et al. (2011). MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines. Biopharm Drug Dispos 32: 355-367.
126. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A, (2004). Identification of mammalian microRNA host genes and transcription units. Genome Res 14 (10A): 1902-1910.
127. Rottiers V, Obad S, Petri A, McGarrah R, Lindholm MW, Black JC, et al. (2013). Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR. Sci Transl Med 5: 212ra162.
128. Rowland A, Miners JO, Mackenzie PI, (2013). The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. Int J Biochem Cell Biol 45: 1121-1132.
129. Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TF, et al. (2008). MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood 112: 4202-4212.
130. Sandhu SK, Volinia S, Costinean S, Galasso M, Neinast R, Santhanam R, et al. (2012). miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Emu-miR-155 transgenic mouse model. Proc Natl Acad Sci U S A 109: 20047-20052.
131. Sato F, Tsuchiya S, Meltzer SJ, Shimizu K, (2011). MicroRNAs and epigenetics. FEBS J 278: 1598-1609.
132. Schrenk D, Baus PR, Ermel N, Klein C, Vorderstemann B, Kauffmann HM, (2001). Up-regulation of transporters of the MRP family by drugs and toxins. Toxicol Lett 120: 51-57.
133. Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC, (2006). Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 66: 1277-1281.
134. Seitz H, Royo H, Bortolin ML, Lin SP, Ferguson-Smith AC, Cavaille J, (2004). A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res 14: 1741-1748.
135. Shan G, Li Y, Zhang J, Li W, Szulwach KE, Duan R, et al. (2008). A small molecule enhances RNA interference and promotes microRNA processing. Nat Biotechnol 26: 933-940.
136. Shen Q, Yao Q, Sun J, Feng L, Lu H, Ma Y, et al. (2014). Downregulation of histone deacetylase 1 by microRNA-520h contributes to the chemotherapeutic effect of doxorubicin. FEBS Lett 588: 184-191.
137. Shibahara Y, Miki Y, Onodera Y, Hata S, Chan MS, Yiu CC, et al. (2012). Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1. J Pathol 227: 357-366.
138. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, et al. (1996). Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 56: 2979-2984.
139. Simon D, Laloo B, Barillot M, Barnetche T, Blanchard C, Rooryck C, et al. (2010). A mutation in the 3'-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia. Hum Mol Genet 19: 2015-2027.
140. Smith NF, Mani S, Schuetz EG, Yasuda K, Sissung TM, Bates SE, et al. (2010). Induction of CYP3A4 by vinblastine: role of the nuclear receptor NR1I2. Ann Pharmacother 44: 1709-1717.
141. Snoke JE, Bloch K, (1955). Studies on the mechanism of action of glutathione synthetase. J Biol Chem 213: 825-835.
142. Song KH, Li T, Owsley E, Chiang JY, (2010). A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes. J Lipid Res 51: 2223-2233.
143. Stefani G, Slack FJ, (2008). Small non-coding RNAs in animal development. Nature reviews 9: 219-230.
144. Takagi S, Nakajima M, Mohri T, Yokoi T, (2008). Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem 283: 9674-9680.
145. Takagi S, Nakajima M, Kida K, Yamaura Y, Fukami T, Yokoi T, (2010). MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle. J Biol Chem 285: 4415-4422.
146. Takahashi K, Oda Y, Toyoda Y, Fukami T, Yokoi T, Nakajima M, (2014). Regulation of cytochrome b5 expression by miR-223 in human liver: effects on cytochrome P450 activities. Pharm Res 31: 780-794.
147. Takata A, Otsuka M, Yoshikawa T, Kishikawa T, Hikiba Y, Obi S, et al. (2013). MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression. Hepatology 57: 162-170.
148. Takei Y, Takigahira M, Mihara K, Tarumi Y, Yanagihara K, (2011). The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer. Cancer Res 71: 1442-1453.
149. Tamarapu Parthasarathy P, Galam L, Huynh B, Yunus A, Abuelenen T, Castillo A, et al. (2012). MicroRNA 16 modulates epithelial sodium channel in human alveolar epithelial cells. Biochem Biophys Res Commun 426: 203-208.
150. Tang L, Pu Y, Wong DK, Liu T, Tang H, Xiang T, et al. (2011). The hepatitis B virus-associated estrogen receptor alpha (ERalpha) was regulated by microRNA-130a in HepG2.2.15 human hepatocellular carcinoma cells. Acta Biochim Biophys Sin (Shanghai) 43: 640-646.
151. Thomson DW, Bracken CP, Goodall GJ, (2011). Experimental strategies for microRNA target identification. Nucleic Acids Res 39: 6845-6853.
152. Thulin P, Wei T, Werngren O, Cheung L, Fisher RM, Grander D, et al. (2013). MicroRNA-9 regulates the expression of peroxisome proliferator-activated receptor δ in human monocytes during the inflammatory response. Int J Mol Med 31: 1003-1010.
153. Tili E, Michaille JJ, Luo Z, Volinia S, Rassenti LZ, Kipps TJ, et al. (2012). The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. Blood 120: 2631-2638.
154. To KK, Zhan Z, Litman T, Bates SE, (2008). Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line. Mol Cell Biol 28: 5147-5161.
155. To KK, Robey RW, Knutsen T, Zhan Z, Ried T, Bates SE, (2009). Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. Mol Cancer Ther 8: 2959-2968.
156. Tong JL, Zhang CP, Nie F, Xu XT, Zhu MM, Xiao SD, et al. (2011). MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells. FEBS Lett 585: 3560-3568.
157. Tsuchiya Y, Nakajima M, Takagi S, Taniya T, Yokoi T, (2006). MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Res 66: 9090-9098.
158. Uchida Y, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Kawahara K, et al. (2013). MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines. Urol Oncol 31: 115-123.
159. Utomo A, Jiang X, Furuta S, Yun J, Levin DS, Wang YC, et al. (2004). Identification of a novel putative non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) essential for alleviating oxidative stress generated from polyunsaturated fatty acids in breast cancer cells. J Biol Chem 279: 43522-43529.
160. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, et al. (2008). Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 322: 1695-1699.
161. Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, et al. (2013). The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342: 971-976.
162. Vinod M, Chennamsetty I, Colin S, Belloy L, De Paoli F, Schaider H, et al. (2014). miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophages. Biochim Biophys Acta 1841: 827-835.
163. Vreugdenhil E, Verissimo CS, Mariman R, Kamphorst JT, Barbosa JS, Zweers T, et al. (2009). MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain. Endocrinology 150: 2220-2228.
164. Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, et al. (2010). Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330: 831-835.
165. Wang F, Xue X, Wei J, An Y, Yao J, Cai H, et al. (2010). hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Br J Cancer 103: 567-574.
166. Wang F, Li T, Zhang B, Li H, Wu Q, Yang L, et al. (2013a). MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. Biochem Biophys Res Commun 434: 688-694.
167. Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu R, et al. (2011). MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis 32: 1033-1042.
168. Wang JH, Shih KS, Wu YW, Wang AW, Yang CR, (2013b). Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1beta signaling in osteoarthritis fibroblast-like synoviocytes. Osteoarthritis Cartilage 21: 1987-1996.
169. Wang L, Oberg AL, Asmann YW, Sicotte H, McDonnell SK, Riska SM, et al. (2009). Genome-wide transcriptional profiling reveals microRNA-correlated genes and biological processes in human lymphoblastoid cell lines. PLoS ONE 4: e5878.
170. Wang Z, Schuetz EG, Xu Y, Thummel KE, (2013c). Interplay between vitamin D and the drug metabolizing enzyme CYP3A4. J Steroid Biochem Mol Biol 136: 54-58.
171. Wei Z, Jiang S, Zhang Y, Wang X, Peng X, Meng C, et al. (2014). The effect of microRNAs in the regulation of human CYP3A4: a systematic study using a mathematical model. Sci Rep 4: 4283.
172. Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, et al. (2009). The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11: 1487-1495.
173. Xiang Y, Ma N, Wang D, Zhang Y, Zhou J, Wu G, et al. (2014). MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine. Oncogene 33: 378-386.
174. Xie L, Zhang Z, Tan Z, He R, Zeng X, Xie Y, et al. (2014). microRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer. Mol Cell Biochem 392: 153-159.
175. Xiong J, Yu D, Wei N, Fu H, Cai T, Huang Y, et al. (2010). An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J 277: 1684-1694.
176. Yang D, Wang G, Zhu S, Liu Q, Wei T, Leng Y, et al. (2014). MiR-495 suppresses mesendoderm differentiation of mouse embryonic stem cells via the direct targeting of Dnmt3a. Stem Cell Res 12: 550-561.
177. Yin KJ, Deng Z, Hamblin M, Xiang Y, Huang H, Zhang J, et al. (2010). Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury. J Neurosci 30: 6398-6408.
178. Yu AM, (2007). Small interfering RNA in drug metabolism and transport. Curr Drug Metab 8: 700-708.
179. Yu AM, (2009). Role of microRNAs in the regulation of drug metabolism and disposition. Expert Opin Drug Metab Toxicol 5: 1513-1528.
180. Yu X, Dhakal IB, Beggs M, Edavana VK, Williams S, Zhang X, et al. (2010). Functional genetic variants in the 3'-untranslated region of sulfotransferase isoform 1A1 (SULT1A1) and their effect on enzymatic activity. Toxicol Sci 118: 391-403.
181. Zhan M, Qu Q, Wang G, Zhou H, (2013). Let-7c sensitizes acquired cisplatin-resistant A549 cells by targeting ABCC2 and Bcl-XL. Pharmazie 68: 955-961.
182. Zhang H, Zhao M, Lv Z, Zhang X, Qin X, Wang H, et al. (2013). MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer. Cell Physiol Biochem 31: 56-65.
183. Zhang M, Wu JF, Chen WJ, Tang SL, Mo ZC, Tang YY, et al. (2014). MicroRNA-27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages. Atherosclerosis 234: 54-64.
184. Zhang X, Zhu J, Xing R, Tie Y, Fu H, Zheng X, et al. (2012). miR-513a-3p sensitizes human lung adenocarcinoma cells to chemotherapy by targeting GSTP1. Lung Cancer 77: 488-494.
185. Zhang Y, Yan LX, Wu QN, Du ZM, Chen J, Liao DZ, et al. (2011). miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res 71: 3552-3562.
186. Zhao J, Lammers P, Torrance CJ, Bader AG, (2013). TP53-independent function of miR-34a via HDAC1 and p21(CIP1/WAF1.). Mol Ther 21: 1678-1686.
187. Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, et al. (2008). MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem 283: 31079-31086.
188. Zhao R, Feng J, He G, (2014). miR-613 regulates cholesterol efflux by targeting LXRα and ABCA1 in PPARγ activated THP-1 macrophages. Biochem Biophys Res Commun 448: 329-334.
189. Zhao S, Wang Y, Liang Y, Zhao M, Long H, Ding S, et al. (2011a). MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum 63: 1376-1386.
190. Zhao Y, Deng C, Lu W, Xiao J, Ma D, Guo M, et al. (2011b). let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor alpha signaling in breast cancer. Mol Med 17: 1233-1241.
191. Zheng L, Lv GC, Sheng J, Yang YD, (2010). Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD. J Gastroenterol Hepatol 25: 156-163.
192. Zhong D, Zhang Y, Zeng YJ, Gao M, Wu GZ, Hu CJ, et al. (2013). MicroRNA-613 represses lipogenesis in HepG2 cells by downregulating LXRα. Lipids Health Dis 12: 32.
193. Zhou J, Wang KC, Wu W, Subramaniam S, Shyy JY, Chiu JJ, et al. (2011). MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc Natl Acad Sci U S A 108: 10355-10360.
194. Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG, et al. (2008). Role of microRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 76: 582-588.
195. Zhu Y, Yu F, Jiao Y, Feng J, Tang W, Yao H, et al. (2011). Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5. Clin Cancer Res 17: 7105-7115.